New 52 Week High Today

Amylyx Pharmaceuticals Inc AMLX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
38.68UNCH (UNCH)
Volume
5,140
Close
38.68UNCH (UNCH)
Volume
781,871
52 week range
6.51 - 41.93
Loading...
  • Open40.73
  • Day High41.93
  • Day Low38.27
  • Prev Close38.68
  • 52 Week High41.93
  • 52 Week High Date01/30/23
  • 52 Week Low6.51
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.563B
  • Shares Out66.26M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change4.68

KEY STATS

  • Open40.73
  • Day High41.93
  • Day Low38.27
  • Prev Close38.68
  • 52 Week High41.93
  • 52 Week High Date01/30/23
  • 52 Week Low6.51
  • 52 Week Low Date05/12/22
  • Market Cap2.563B
  • Shares Out66.26M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change4.68

RATIOS/PROFITABILITY

  • EPS (TTM)-3.28
  • P/E (TTM)-11.81
  • Fwd P/E (NTM)-13.35
  • EBITDA (TTM)-184.736M
  • ROE (TTM)-1,844.02%
  • Revenue (TTM)344,999.999
  • Gross Margin (TTM)50.14%
  • Net Margin (TTM)-53,337.68%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/30/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amylyx Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX003 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS). The Company is developing AMX0035 for other neurodegenerative diseases...
George Milne Ph.D.
Independent Non-Executive Chairman of the Board
James Frates
Chief Financial Officer
Gina Mazzariello
Chief Legal Officer and General Counsel
Address
43 THORNDIKE STREET
Cambridge, MA
02141
United States

Top Peers

SYMBOLLASTCHG%CHG
VTYX
Ventyx Biosciences Inc
42.05UNCHUNCH
XENE
Xenon Pharmaceuticals Inc
38.00UNCHUNCH
AKRO
Akero Therapeutics Inc
48.71UNCHUNCH
RVMD
Revolution Medicines Inc
26.82UNCHUNCH
SAGE
SAGE Therapeutics Inc
43.15UNCHUNCH